Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBT Margin (2016 - 2025)

Historic EBT Margin for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to 4.02%.

  • OptimizeRx's EBT Margin rose 506800.0% to 4.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.54%, marking a year-over-year increase of 393400.0%. This contributed to the annual value of 21.04% for FY2024, which is 141400.0% up from last year.
  • Latest data reveals that OptimizeRx reported EBT Margin of 4.02% as of Q3 2025, which was up 506800.0% from 5.87% recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's EBT Margin ranged from a high of 6.83% in Q4 2024 and a low of 49.2% during Q1 2023
  • Moreover, its 5-year median value for EBT Margin was 17.54% (2023), whereas its average is 16.99%.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -397300bps in 2023, then soared by 506800bps in 2025.
  • Quarter analysis of 5 years shows OptimizeRx's EBT Margin stood at 3.07% in 2021, then plummeted by -154bps to 1.66% in 2022, then plummeted by -2396bps to 41.38% in 2023, then soared by 117bps to 6.83% in 2024, then plummeted by -41bps to 4.02% in 2025.
  • Its EBT Margin stands at 4.02% for Q3 2025, versus 5.87% for Q2 2025 and 14.98% for Q1 2025.